SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-070389
Filing Date
2020-06-05
Accepted
2020-06-05 17:01:10
Documents
12
Period of Report
2020-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2021954-1_8k.htm   iXBRL 8-K 38257
  Complete submission text file 0001104659-20-070389.txt   215334

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cara-20200604.xsd EX-101.SCH 3210
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20200604_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20200604_pre.xml EX-101.PRE 22726
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2021954-1_8k_htm.xml XML 3729
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 20947079
SIC: 2834 Pharmaceutical Preparations